Compare INSE & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSE | RNAC |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.3M | 204.6M |
| IPO Year | N/A | 2016 |
| Metric | INSE | RNAC |
|---|---|---|
| Price | $8.92 | $7.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $13.50 | ★ $38.40 |
| AVG Volume (30 Days) | 182.0K | ★ 219.7K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $309,900,000.00 | $1,091,000.00 |
| Revenue This Year | $4.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.66 | ★ N/A |
| Revenue Growth | ★ 4.98 | N/A |
| 52 Week Low | $6.51 | $5.98 |
| 52 Week High | $11.61 | $20.30 |
| Indicator | INSE | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 47.21 |
| Support Level | $8.79 | $7.21 |
| Resistance Level | $9.34 | $9.23 |
| Average True Range (ATR) | 0.42 | 0.67 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 55.52 | 36.30 |
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.